The artificial tendons and ligaments market was valued at $64.3 million in 2021 and is estimated to reach $165.7 million by 2031, growing at a CAGR of 10.1% from 2022 to 2031.
Artificial tendons and ligament tools intended to reinforce or replace natural tendons, and ligaments, including any necessary fixing devices. Artificial tendons are also used to treat torn and damaged tendons. The damaged area may feel weak or painful. Tendons are soft, band-like tissues that connect muscles to bone. Ligaments are fibrous connective tissue that connects one bone to another bone. When the muscles contract, the tendons pull the bones and cause the joints to move. When tendon damage occurs, movement may be seriously limited. The joints that are most commonly affected by tendon injuries are the shoulders, elbows, ankles, thighs, knees, and fingers. According to the American Academy of Orthopedic Surgeons, “jersey finger” is one of the most common sports injuries affecting the tendons. Tendon damage can also occur in rheumatoid arthritis, an inflammatory disease of the joints. Rheumatoid arthritis can involve the tendons, causing them to tear.
The damaged tendon and ligaments can be treated by replacement from artificial tendons and ligaments. The replacement of artificial tendons and ligaments is done to bring back normal movement to a joint. In tendons and ligament surgery, a surgeon will make one or more small incisions (cuts) in the skin over the damaged tendon, replace the damaged tendon or ligament, and sew the torn ends of the tendon together. After, check the surrounding tissue to make sure no other injuries, such as injury to the blood vessels or nerves have occurred, and then close the incision and cover the area with sterile bandages or dressings. After surgery, the surgeon will suggest immobilizing or splinting the joint to allow the tendon to heal.
Major factors driving the growth of the artificial tendons and ligaments market include an increase in the geriatric population, a rise in sports-related injuries such as sprains, strains, tendinitis, and contusions, the surge in incidences of tendon and wrist injuries, and an increase in interest in other workouts and physical activities among children and adults. For instance, according to a John Hopkins Medicine article in 2019,30 million individuals participate in organized sports, resulting in more than 3.5 million sports injuries annually in the U. S. alone, with sprains and strains.
Tendon injury mostly occurs during hard physical work out such as rowing, heavy weight lifting, occupation activities such as window washing, woodwork, some assembly line works, and sports activities such as football, basketball, pedal cycling, soccer, ice or roller skating, and skateboarding. Artificial muscles and tendons for knee, ankle, and tendon reinforcement will also become increasingly popular due to a growing propensity for minimally invasive procedures, government activities to raise awareness about sports injuries, and developments in surgical methods.
Moreover, the surge in accidents causes tendons and ligament damage, particularly road accidents leading to an increase in the number of artificial tendons and ligament surgeries, thus fueling the growth of the artificial tendons and ligament market. For instance, according to Accident and Emergency (A&E) statistics, 24.8 million sports injuries were recorded in 2019, an increase of 2% compared with 2018. Furthermore, an increase in demand for minimally invasive procedures propels the adoption of artificial tendons and ligaments product.
In addition, technological advancements; the launch of various products; strategies among key players such as acquisition, collaboration, and agreement drive the growth of the artificial tendons and ligaments market
For instance, in 2021, Striker launched its Citrelock tendon fixation devices system for orthopedic surgical applications. The new system provides surgeons with a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, which has unique chemical and mechanical properties for orthopedic surgical applications. The launch of Citrelock will help the company to strengthen its orthopedics portfolio.
However, the lack of acceptance for biological products and the lack of appropriate knowledge regarding products among physicians and surgeons limit the market growth. Stricter regulatory standards and high costs for artificial tendons and ligament products also restrain market growth. Furthermore, the healthcare business is predicted to witness growth, owing to a rise in the prevalence of tendonitis and obesity, an increase in R&D investments in drug discovery & development, and a rise in awareness regarding physical fitness and workout. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.
The artificial tendons and ligaments market is segmented on the basis of application, end user, and region. On the basis of application, the market is classified into knee Injuries, Shoulder Injuries, foot and ankle injuries, and others. Depending on the end user, it is segmented into hospitals and clinics, and ambulatory surgery centers. The artificial tendons and ligaments market is studied across North America (the U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
Major players profiled in the report are Artelon, Arthrex, Inc., Corin Group, Enovis, Exactech, Inc., FX-Global Inc., Group FH Communication, Integra Lifesciences, Neoligaments, Stryker Corporation.
Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the artificial tendons and ligaments market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes analysis of the regional as well as global artificial tendons and ligaments market trends, key players, market segments, application areas, and market growth strategies.
Artificial tendons and ligament tools intended to reinforce or replace natural tendons, and ligaments, including any necessary fixing devices. Artificial tendons are also used to treat torn and damaged tendons. The damaged area may feel weak or painful. Tendons are soft, band-like tissues that connect muscles to bone. Ligaments are fibrous connective tissue that connects one bone to another bone. When the muscles contract, the tendons pull the bones and cause the joints to move. When tendon damage occurs, movement may be seriously limited. The joints that are most commonly affected by tendon injuries are the shoulders, elbows, ankles, thighs, knees, and fingers. According to the American Academy of Orthopedic Surgeons, “jersey finger” is one of the most common sports injuries affecting the tendons. Tendon damage can also occur in rheumatoid arthritis, an inflammatory disease of the joints. Rheumatoid arthritis can involve the tendons, causing them to tear.
The damaged tendon and ligaments can be treated by replacement from artificial tendons and ligaments. The replacement of artificial tendons and ligaments is done to bring back normal movement to a joint. In tendons and ligament surgery, a surgeon will make one or more small incisions (cuts) in the skin over the damaged tendon, replace the damaged tendon or ligament, and sew the torn ends of the tendon together. After, check the surrounding tissue to make sure no other injuries, such as injury to the blood vessels or nerves have occurred, and then close the incision and cover the area with sterile bandages or dressings. After surgery, the surgeon will suggest immobilizing or splinting the joint to allow the tendon to heal.
Major factors driving the growth of the artificial tendons and ligaments market include an increase in the geriatric population, a rise in sports-related injuries such as sprains, strains, tendinitis, and contusions, the surge in incidences of tendon and wrist injuries, and an increase in interest in other workouts and physical activities among children and adults. For instance, according to a John Hopkins Medicine article in 2019,30 million individuals participate in organized sports, resulting in more than 3.5 million sports injuries annually in the U. S. alone, with sprains and strains.
Tendon injury mostly occurs during hard physical work out such as rowing, heavy weight lifting, occupation activities such as window washing, woodwork, some assembly line works, and sports activities such as football, basketball, pedal cycling, soccer, ice or roller skating, and skateboarding. Artificial muscles and tendons for knee, ankle, and tendon reinforcement will also become increasingly popular due to a growing propensity for minimally invasive procedures, government activities to raise awareness about sports injuries, and developments in surgical methods.
Moreover, the surge in accidents causes tendons and ligament damage, particularly road accidents leading to an increase in the number of artificial tendons and ligament surgeries, thus fueling the growth of the artificial tendons and ligament market. For instance, according to Accident and Emergency (A&E) statistics, 24.8 million sports injuries were recorded in 2019, an increase of 2% compared with 2018. Furthermore, an increase in demand for minimally invasive procedures propels the adoption of artificial tendons and ligaments product.
In addition, technological advancements; the launch of various products; strategies among key players such as acquisition, collaboration, and agreement drive the growth of the artificial tendons and ligaments market
For instance, in 2021, Striker launched its Citrelock tendon fixation devices system for orthopedic surgical applications. The new system provides surgeons with a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, which has unique chemical and mechanical properties for orthopedic surgical applications. The launch of Citrelock will help the company to strengthen its orthopedics portfolio.
However, the lack of acceptance for biological products and the lack of appropriate knowledge regarding products among physicians and surgeons limit the market growth. Stricter regulatory standards and high costs for artificial tendons and ligament products also restrain market growth. Furthermore, the healthcare business is predicted to witness growth, owing to a rise in the prevalence of tendonitis and obesity, an increase in R&D investments in drug discovery & development, and a rise in awareness regarding physical fitness and workout. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.
The artificial tendons and ligaments market is segmented on the basis of application, end user, and region. On the basis of application, the market is classified into knee Injuries, Shoulder Injuries, foot and ankle injuries, and others. Depending on the end user, it is segmented into hospitals and clinics, and ambulatory surgery centers. The artificial tendons and ligaments market is studied across North America (the U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
Major players profiled in the report are Artelon, Arthrex, Inc., Corin Group, Enovis, Exactech, Inc., FX-Global Inc., Group FH Communication, Integra Lifesciences, Neoligaments, Stryker Corporation.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial tendons and ligaments market analysis from 2021 to 2031 to identify the prevailing artificial tendons and ligaments market opportunities.Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the artificial tendons and ligaments market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes analysis of the regional as well as global artificial tendons and ligaments market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Application
- Foot and Ankle Injuries
- Knee Injuries
- Shoulder Injuries
- Others
By End users
- Hospitals and Clinics
- ASCs
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- Arthrex, Inc.
- fx solutions
- Orthomed S. A. S
- Neoligaments
- Artelon
- Corin Groups
- Mathys AG
- F H Orthopedics
- Integra Lifesciences Corporation
- Stryker Corporation
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Knee Injuries
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Shoulder Injuries
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4 Foot and Ankle Injuries
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
4.5 Others
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market share analysis by country
CHAPTER 5: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals and Clinics
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 ASCs
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Application
6.2.3 North America Market size and forecast, by End users
6.2.4 North America Market size and forecast, by country
6.2.4.1 U. S.
6.2.4.1.1 Key market trends, growth factors and opportunities
6.2.4.1.2 Market size and forecast, by Application
6.2.4.1.3 Market size and forecast, by End users
6.2.4.2 Canada
6.2.4.2.1 Key market trends, growth factors and opportunities
6.2.4.2.2 Market size and forecast, by Application
6.2.4.2.3 Market size and forecast, by End users
6.2.4.3 Mexico
6.2.4.3.1 Key market trends, growth factors and opportunities
6.2.4.3.2 Market size and forecast, by Application
6.2.4.3.3 Market size and forecast, by End users
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Application
6.3.3 Europe Market size and forecast, by End users
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Key market trends, growth factors and opportunities
6.3.4.1.2 Market size and forecast, by Application
6.3.4.1.3 Market size and forecast, by End users
6.3.4.2 France
6.3.4.2.1 Key market trends, growth factors and opportunities
6.3.4.2.2 Market size and forecast, by Application
6.3.4.2.3 Market size and forecast, by End users
6.3.4.3 UK
6.3.4.3.1 Key market trends, growth factors and opportunities
6.3.4.3.2 Market size and forecast, by Application
6.3.4.3.3 Market size and forecast, by End users
6.3.4.4 Italy
6.3.4.4.1 Key market trends, growth factors and opportunities
6.3.4.4.2 Market size and forecast, by Application
6.3.4.4.3 Market size and forecast, by End users
6.3.4.5 Spain
6.3.4.5.1 Key market trends, growth factors and opportunities
6.3.4.5.2 Market size and forecast, by Application
6.3.4.5.3 Market size and forecast, by End users
6.3.4.6 Rest of Europe
6.3.4.6.1 Key market trends, growth factors and opportunities
6.3.4.6.2 Market size and forecast, by Application
6.3.4.6.3 Market size and forecast, by End users
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Application
6.4.3 Asia-Pacific Market size and forecast, by End users
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Key market trends, growth factors and opportunities
6.4.4.1.2 Market size and forecast, by Application
6.4.4.1.3 Market size and forecast, by End users
6.4.4.2 China
6.4.4.2.1 Key market trends, growth factors and opportunities
6.4.4.2.2 Market size and forecast, by Application
6.4.4.2.3 Market size and forecast, by End users
6.4.4.3 India
6.4.4.3.1 Key market trends, growth factors and opportunities
6.4.4.3.2 Market size and forecast, by Application
6.4.4.3.3 Market size and forecast, by End users
6.4.4.4 Australia
6.4.4.4.1 Key market trends, growth factors and opportunities
6.4.4.4.2 Market size and forecast, by Application
6.4.4.4.3 Market size and forecast, by End users
6.4.4.5 South Korea
6.4.4.5.1 Key market trends, growth factors and opportunities
6.4.4.5.2 Market size and forecast, by Application
6.4.4.5.3 Market size and forecast, by End users
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Key market trends, growth factors and opportunities
6.4.4.6.2 Market size and forecast, by Application
6.4.4.6.3 Market size and forecast, by End users
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Application
6.5.3 LAMEA Market size and forecast, by End users
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Key market trends, growth factors and opportunities
6.5.4.1.2 Market size and forecast, by Application
6.5.4.1.3 Market size and forecast, by End users
6.5.4.2 South Africa
6.5.4.2.1 Key market trends, growth factors and opportunities
6.5.4.2.2 Market size and forecast, by Application
6.5.4.2.3 Market size and forecast, by End users
6.5.4.3 Saudi Arabia
6.5.4.3.1 Key market trends, growth factors and opportunities
6.5.4.3.2 Market size and forecast, by Application
6.5.4.3.3 Market size and forecast, by End users
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Key market trends, growth factors and opportunities
6.5.4.4.2 Market size and forecast, by Application
6.5.4.4.3 Market size and forecast, by End users
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Players
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Arthrex, Inc.
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 fx solutions
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Orthomed S. A. S
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Neoligaments
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Artelon
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Corin Groups
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Mathys AG
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 F H Orthopedics
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Integra Lifesciences Corporation
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Stryker Corporation
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Artificial Tendons and Ligaments Market,' the Artificial Tendons And Ligaments Market Size was valued at $64.33 million in 2021, and is estimated to reach $165.7 million by 2031, growing at a CAGR of 10.1% from 2022 to 2031.The artificial tendons and ligaments refer to the surgical replacement of damaged or torn tendons, which are cord-like structures made of strong fibrous connective tissue that connect muscles to bones. Tendons are cable-like tissues that connect muscles to bones. Although one of their functions is to take some of the strain off the muscles, too much activity can injure them. The shoulder, elbow, knee, and ankle joints are most commonly affected by tendon injuries. Artificial tendons and ligament surgeries are preferred for the treatment of tendonitis and damaged tendons and ligaments. Tendinitis occurs when a tendon becomes irritated or inflamed. This can happen through a sudden injury, but it most commonly occurs due to the impact of a minor, repetitious movement. The symptom of tendinitis is pain with any type of movement of the joint especially overhead motions. In a few cases, pain is observed during sleep and early morning hours.
Tendinitis can affect people of any age, especially if they perform a repetitious movement on a regular basis. However, the vast majority of cases occur in people who are at least 40 years old. Elderly individuals have the biggest risk of suffering from chronic tendinitis due to the reduced elasticity in their tendons. Therefore, the rise in geriatric populations drives the growth of the Artificial Tendons Market. For instance, according to the Population Reference Bureau, in July 2019, the number of Americans aged 65 years, or more is projected to double from an estimated 52 million in 2018 to 95 million by 2060.
Growth of the Artificial Tendons And Ligaments Market Size is majorly driven by a rise in the geriatric population, a surge in the number of patients suffering from tendonitis, a rise in physical exercise among children and adults, an increase in interest in professional sports, and surge in a number of athletes that are prone to a tendon injury. Furthermore, the increase in the number of road injuries related to the injury in the tendons is expected to drive market growth. In addition, a rise in R&D investments in drug discovery and development and a rise in occupation-related injury boosts market growth.
For instance, according to the National Library of Medicine, during the 10-year study period, there was an incidence rate of 33.2 injuries per 100,000 person-years. Work-related injuries accounted for 24.9% of acute traumatic tendon injuries. Out of total work-related injuries, occurred in construction and extraction occupations (44.2%), food preparation and serving-related occupations (14.4%), and transportation and material moving occupations (12.5%). Thus, the above-mentioned factors are anticipated to fuel the adoption of such products in the artificial tendons and ligaments industry products.
On the basis of the application of artificial tendons and ligaments, the knee injuries segment generated maximum revenue in 2021 and is expected to witness the highest CAGR during the artificial tendons and ligaments market forecast period, owing to a rise in physical exercise among children and adults, increase in interest of professional sports, and increase in a number of athletes that are prone to knee injuries.
On the basis of end-user, the ambulatory surgery centers (ASCs) segment is expected to witness the highest CAGR during the forecast period, owing to a surge in the number of artificial tendons and ligaments surgeries and an increase in the availability of technically skilled nurses for private practices
Depending on the region, Asia-Pacific Artificial Tendons And Ligaments industry is expected to witness the highest CAGR during the forecast period, owing to the rise in the geriatric population, and emerging economies, and to fulfill the growing demands in developing countries such as India and China.
KEY FINDINGS OF THE STUDY
On the basis of type of application, the knee injuries segment held the largest share in the Artificial Tendons And Ligaments Market Share in 2021 and is expected to remain dominant during the forecast period.By end users, Artificial Tendons And Ligaments Market Share were dominated by the hospitals and clinics segment in 2021.
On the basis of region, North America held the largest market share in 2021.
The report includes Artificial Tendons And Ligaments Market Analysis of the regional as well as global Artificial Tendons And Ligaments Market trends, key players, market segments, application areas, Growth strategies
Companies Mentioned
- Arthrex, Inc.
- Fx Solutions
- Orthomed SAS
- Neoligaments
- Artelon
- Corin Groups
- Mathys AG
- F H Orthopedics
- Integra Lifesciences Corporation
- Stryker Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 240 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 64.3 million |
| Forecasted Market Value ( USD | $ 165.7 million |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
